´ëÇѳúÀüÁõÇÐȸ Á¦6Â÷ ÄÉÅæ»ý¼º ½ÄÀÌÄ¡·á ±Û·Î¹ú ½ÉÆ÷Áö¾ö (6th Global Symposium on Ketogenic Therapies for Neurological Disorders) : 2018-10-07±³À°ÀÏÀÚ : 2018-10-07
±³À°Àå¼Ò : Á¦ÁÖ±¹Á¦ÄÁº¥¼Ç¼¾ÅÍ 3Ãþ ÇѶóȦ, »ï´ÙȦ
±³À°ÁÖÁ¦ :
Á¦6Â÷ ÄÉÅæ»ý¼º ½ÄÀÌÄ¡·á ±Û·Î¹ú ½ÉÆ÷Áö¾ö (6th Global Symposium on Ketogenic Therapies for Neurological Disorders) ÁÖÃÖ±â°ü : ´ëÇѳúÀüÁõÇÐȸ
´ã´çÀÚ : ¾çÇýºó
¿¬¶ôó : 02-3452-7245
À̸ÞÀÏ :
keto@insession.co.kr ±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú, ½Å°æ°ú
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
Á¦ÁÖƯº°ÀÚÄ¡µµ±³À°½Ã°£ : 10 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 400,000¿ø
ºñ°í »çÀüµî·Ï (8¿ù 31ÀϱîÁö) Àü¹®ÀÇ/¹Ú»ç: 300,000¿ø Àü°øÀÇ/¿µ¾ç»ç/°£È£»ç µî: 200,000¿ø ÇöÀåµî·Ï Àü¹®ÀÇ/¹Ú»ç: 400,000¿ø Àü°øÀÇ/¿µ¾ç»ç/°£È£»ç µî: 300,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ ÇѶóȦ 08:00~08:30 Basic mechanism of KD action Jong Rho(University of Calgary, Canada)
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ ÇѶóȦ 08:30~09:00 Ketogenic diets in inborn disorders of metabolism - new ways of thinking Sabine Scholl-Bürgi(University of Innsbruck, Austria)
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ ÇѶóȦ 09:00~09:30 Clinical trial design for KD therapies - promoting international collaboration Ki Joong Kim(Seoul National University, Korea)
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ ÇѶóȦ 09:30~10:00 Designing a KD study with gut microbiota Se Heon Kim(Korea University, Korea)
Åä·Ð 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ ÇѶóȦ 10:00~10:10 Discussion ()
ÈÞ½Ä 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ ÇѶóȦ 10:10~10:30 Break ()
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ ÇѶóȦ 10:30~10:55 What is the impact of the microbiome on brain cellular metabolism? Jong Rho(University of Calgary, Canada)
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ ÇѶóȦ 10:55~11:20 An overview of human and model organism microbiomes In-Geol Choi(Korea University, Korea)
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ ÇѶóȦ 11:20~11:45 Potential role of microbiota in immunity and epilepsy Derrick Chan Wei Shih(KK Women)
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ ÇѶóȦ 11:45~12:10 Effects of the KD in experimental models of neurological disease Jane Shearer(University of Calgary, Canada)
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ »ï´ÙȦ 10:30~10:55 KD treatment and sleep in epilepsy Ming-Yu Chang(Chang Gung University, Taiwan)
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ »ï´ÙȦ 10:55~11:20 Mediterranean diet and sleep Walter Currenti(University of Cantania, Italy)
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ »ï´ÙȦ 11:20~11:45 Intermittent fasting and sleep Hyang Woon Lee(Ewha Womans University, Korea)
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ »ï´ÙȦ 11:45~12:10 Temporal effects of the KD on cardiac-respiratory pathology in a model of SUDEP Kristina Simeone(Creighton University, USA)
ÈÞ½Ä 10¿ù 07ÀÏ 12:10~13:30 Lunch ()
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ ÇѶóȦ 13:30~13:55 KD therapy for super-refractory status epilepticus Mackenzie Cervenka(Johns Hopkins University, USA)
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ ÇѶóȦ 13:55~14:30 Pearls and pitfalls for emergency KD use in pediatrics Rima Nabbout(Necker Enfants Malades Hospital, France)
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ ÇѶóȦ 14:20~14:45 Parenteral vs. enteral ketosis induction in super-refractory status epilepticus Sirinuch Chomtho(Chulalongkorn University, Thailand)
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ ÇѶóȦ 14:45~15:10 Favorable factors for KD response in super-refractory status epilepticus Jeehun Lee(Sungkyunkwan University, Korea)
Åä·Ð 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ ÇѶóȦ 15:10~15:20 Discussion ()
ÈÞ½Ä 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ ÇѶóȦ 15:20~15:40 Break ()
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ ÇѶóȦ 15:40~16:00 Clinical spectrum and genetic mechanism of Glut1-DS Yasushi Ito(Tokyo Women¡¯s Medical University, Japan))
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ ÇѶóȦ 16:00~16:20 Have we done wrong? long term follow-up of cardiovascular risk factors in Glut1 deficiency treated with KD therapies Nicole Heussinger(Children)
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ ÇѶóȦ 16:20~16:40 Use and potential of the modified Atkins Diet in Glut1D Jeong A Kim(Yonsei University, Korea)
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ ÇѶóȦ 16:40~17:00 The future therapy of Glut1D; triheptanoin and ketoesters Hoon-Chul Kang(Yonsei University, Korea)
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ ÇѶóȦ 17:00~17:20 Glut1D and KD: where will we be in 2025? Joerg Klepper(Children)
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ »ï´ÙȦ 15:40~16:05 Regulation of systemic inflammation by metabolic substrates Emily Goldberg(Yale University, USA)
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ »ï´ÙȦ 16:05~16:30 Anti-inflammatory targets for epilepsy: drugs vs. diets Sookyong Koh(Emory University, USA)
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ »ï´ÙȦ 16:30~16:55 Role of KD therapy in autoimmune encephalitis I-Jun Chou(Chang Gung Children¡¯s Hospital, Taiwan)
±³À°½Ã°£ 10¿ù 07ÀÏ Á¦ÁÖ ICC 3Ãþ »ï´ÙȦ 16:55~17:20 Clinical studies and anti-inflammatory mechanisms of diet treatments Stephane Auvin(Paris-Diderot University, France)